Medicines design Flashcards

1
Q

What is salbutamol?

A
  • A SABA (short-onset, short duration bronchodilator)
  • treating symptoms of asthma and COPD
  • provide short-term relief
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 4 methods of structural modification for SAR?

A
  • Chain extension
  • Conformational restriction
  • Group shifting
  • Chiral switching
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the 4 methods of choosing a lead compound?

A
  • Natural receptor ligands (ACh, NA)
  • Collection of synthetic compounds
  • Existing drugs
  • Natural products (muscarine)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the 2 types of cholinergic receptor?

A

Nicotinic
Muscarinic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Whats the difference between b1 and b2 adrenoceptors?

A

b1 contracts cardiac muscle, found in heart
b2 relaxes smooth muscle, found in airways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the 2 enveloped proteins contained in influenza viruses and what do they do?

A

Haemagglutinin (HA): functions in attachment and penetration
Neuraminidase (NA): a glycoside hydrolase that cleaves glycosidic linkages, and faciliates virus release from infected cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How does the structure of Haemagglutinin aid its role?

A

Haemagglutinin protein is comprised of two domains.
- Globular head
- Fibrous stem

The globular head of Haemagglutinin binds to the cell surface receptor sialic acid, the tail is latched to the membrane of the cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the function of neuraminidase?

A

Neuraminidase (N) protein is an enzyme that breaks down the sialic acid receptor on the cell surface to gain entry.

Many pathogens have acquired neuraminidases to facilitate infection

Once sialic acid is removed from the receptor by neuraminidase, the Heamagglutinin protein no longer binds.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the innate response to influenza?

A

NFκB transcription thus leads to pro-inflammatory cytokine gene expression of TNFα, IFNβ and IL-8.

Chemokines and cytokines produced increase inflammatory response by attracting NK, B and T cells to the infection site.

These cells still continue to produce more inflammatory cytokines to keep the Th1 response cycle going

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is NFκB?

A

Nuclear factor kappa-light-chain-enhancer of activated B cells.
It is a family of transcription factor protein complexes that controls transcription of DNA, cytokine production and cell survival.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the 6 long term responses to influenza infection?

A
  • IFNγ boosts chemokine gene expression, activation of macrophages, antigen presentation and continual development of specific cell-mediated immunity.
  • Th2 response
  • T cell stimulation
  • Antigen Presentation
  • B cell maturation
  • Antigen-specific IgG production
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is IFNγ?

A

Interferon-gamma
A cytokine that activates of macrophages to increase phagocytosis and intracellular killing of pathogens.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the 4 types of influenza virus?

A

A, B, C and D.

Human influenza A and B viruses cause seasonal epidemics of disease almost every winter.

Influenza type C infections generally cause a mild respiratory illness and are not thought to cause epidemics.

Influenza D viruses primarily affect cattle and are not known to infect or cause illness in people.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are influenza A sub-types?

A

Influenza A viruses are divided into subtypes based the hemagglutinin and neuraminidase

There are 18 different hemagglutinin subtypes and 11 different neuraminidase subtypes.

Current subtypes of influenza A viruses found in people are influenza A (H1N1) and influenza A (H3N2) viruses.

An IgG antibody will only recognise the ONE sub-type of H or N it was generated against

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is antigenic drift?

A

Gradual accumulation of amino acid mutations that allow the hemagglutinin to escape neutralizing antibodies

Epidemic strains of influenza are thought to have changes in three or more antigenic sites

Antigenic drift results in a reduced ability of circulating antibodies to recognise the ‘new’ virus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is seasonal flu?

A
  • Most common form and usually comprises a variant of a previous strain
  • We can anticipate the likely strain to emerge and prepare vaccines in preparedness
  • As the new strain is usually derived from a previous strain, much of the population will already have at least partial immune protection
  • While seasonal influenza (flu) viruses can be detected year-round, flu viruses are most common during the winter.
  • Most of the time flu activity peaks between December and February, although activity can last as late as May.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How are influenza vaccines made?

A
  • These vaccines are produced by growing the bacteria or virus in culture media then inactivating it with heat and/or chemicals (usually formalin).
  • Inactivated vaccines are not alive and cannot replicate. The entire dose of antigen is administered in the injection. These vaccines cannot cause disease from infection, even in an immunodeficient person.
  • In general, the first dose does not produce protective immunity, but only “primes” the immune system. A protective immune response develops after the second or third dose.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the 2 pros and 2 cons of flu vaccines?

A

Pros:
- Generally safer
- Improved stability
Cons:
- Can be costly
- Hypersensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the 4 critical factors of flu vaccines?

A

Growth potential of seed virus
- The quantity of vaccine that can be produced is limited by the least productive strain

Timing of strain selection
- Available production time is limited due to administering vaccine prior to influenza season, seed require 4 weeks for development

Potency test reagents
- Required to determine the potency of monovalent components prior to formulation of vaccine
- Must be produced/standardized for new strains

Timing of Annual License Supplement Approval
- Required to begin packaging process

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How can antigenic shift cause flu pandemics?

A
  • Entire genes encoding a different H or N sub-types is incorporated into the ‘new’ virus, often occuring in animal hosts which are co-infected with two or more strains of influenza
  • No immune history, so no natural protection
  • Impossible to predict the nature of the strain or when it will emerge
  • Can be highly pathogenic and result in high rates of mortality
21
Q

How do adamantanes work?

A

Interfere with the function of the transmembrane domain of the M2 protein of influenza A viruses

Decrease the release of influenza A viral particles into the host cell

22
Q

What is amantidine used for?

A

Amantadine (adults and children ≥ 1 year)

Reduce duration of illness by ~1 day when administered within 2 days of the onset of illness (uncomplicated influenza)

Orally administered (100 mg tablets and syrup for children)

Activity against influenza A viruses only, through inhibiting replication

Has comparable antiviral and clinical activities when used for prophylaxis or treatment

23
Q

What are the problems with amantidine?

A

Rapid development of resistance to amantadine in 30% of treated patients (can develop in 2-5 days)

90% of clinical isolates in the US showed resistance to Amantadine in 2005

Wide range of side effects and toxicity
→ general structure

24
Q

What is ramantidine?

A

Ramantadine was approved in 1993 as a less toxic alternative to amantadine

Structurally similar to amantadine

Similar mechanism of action to amantadine and suffers from many of the same problems, ie. resistance

25
Q

What are the two neuraminidase inhibitors and what do they do?

A

Zanamivir
Oseltamivir
Competitive inhibitors that compete with the natural receptors for access to the neuraminidase active site

26
Q

What are the advantages of neuraminidase inhibitors?

A

Active against all strains of influenza (A,B,C) and all serotypes (including H5N1 and H1N1)

27
Q

How were neuraminidase inhibitors developed?

A
  • The chemical mechanism of influenza neuraminidase was known.
  • Neuraminidase mechanism should be the same for all sub-types of the N protein.
  • Inhibitors were initially developed to mimic the transition state structure of sialic acid.
  • These inhibitors were not selective for influenza neuraminidase (they also inhibited human neuraminidase) and were not very potent
  • In the stucture, there was a large pocket of space near OH-4 group of the sialic acid. This was unique to influenza neuraminidase.
  • There was an acidic amino acid (glutamate) that formed a hydrogen bond with OH-4 group.
28
Q

In which 4 ways was the structure of zanamivir altered to help its purpose?

A
  • A guanadino group was introduced to replace OH-4 group in the original neurominidase inhibitors
  • The compound was now selective for influenza neuraminidase over human neuraminidase as the large guanadino group can fit into the pocket
  • The guanadino group formed a hydrogen bond with the glutamate amino acid.
  • The potency of the compound improved over 1000-fold
29
Q

What are the pk stats of zanamivir?

A
  • Inhalational delivery of dry powered drug (5 mg per package) in a lactose carrier
  • A proprietary device is used to deliver drug (Diskhaler)
  • Approved for treatment of influenza A & B among those aged 7+ years
  • Bioavailability of Zanamivir delivered by inhalation is ~10 to 20%
  • Serum half-life is 2.5 to 5 hours
  • Zanamivir is excreted unchanged by the kidney
30
Q

How was zanamivir modified to make oseltamir?

A

To improve lipophilicity:
- Replaced hydroxyl sidechain with a hydrocarbon sidechain
- Removed guanadino group
- Converted carboxylic acid group to an ester

Removed ring oxygen to improve stability, this also allowed the double bond to be moved (more resembles transition-state).

31
Q

What is the pk of oseltamivir?

A
  • Orally administered: 75 mg tablets and syrup for children
  • Treatment 1 year +
  • Chemoprophylaxis 13 years +
  • Absorption of the pro-drug is high, following de-esterification the bioavailability of the active carboxylate form is 80%

Serum half-life of 8-10 hours
Excreted unchanged by the kidney
Reduces duration of illness by one day if administered within 48 hrs of onset of symptoms

32
Q

What is the arguement for flu drugs vs flu vaccines?

A

Vaccines provide protection against infection, but need to be produced ahead of time and specific vaccine is required for each serotype of influenza

Drugs do not give lasting protection against infection, but are active against all strains and serotypes, can be stored for prolonged periods but can develop resistance

33
Q

How is seasonal flu managed?

A
  • Most common form and usually comprises a variant of a previous strain so much of the population will already have at least partial immune protection.
  • Can anticipate the likely strain to emerge and prepare vaccines ahead as the first line of defense.
  • When the actual strain differs from that predicted, the vaccines may still provide limited protection, but Anti-viral drugs become important for treatment and management.
  • This can also result in small epidemic outbreaks
  • Use of anti-virals in ‘non-risk’ groups is largely for the relief of symptoms.
34
Q

How is a pandemic influenza managed?

A
  • Neuraminidase inhibitors are first line of defense as it is not possible to have vaccines prepared
  • Role of the anti-influenza drug changes to ‘life-saving’ rather than for treatment of symptoms
  • Will be administered more widely for prophylaxis in an effort to reduce the spread of the infection
  • May need to be dispensed at the home by a health care professional, more likely to be prescribed ‘off-license’
35
Q

What is the adrenal cortex?

A

The site of production and secretion of corticosteroids in response to signals from the pituitary gland, following signalling from the hypothalamus

36
Q

What are the 4 things that mineralocorticoids do?

A
  • Reabsorption of Na+ (kidneys)
  • Secretion of K+ (kidneys)
  • Secretion of H+
  • Increase BP and blood volume
37
Q

What are the 4 things that do glucocorticoids do?

A
  • Reduce inflammation
  • Reduce immune response
  • Redistributefat
  • Can cause hyperglycaemia
38
Q

Why are steroids made more potent?

A
  • Molecules with high potency and high selectivity for glucocorticoid activity are desired as treatments for inflammatory diseases
  • Mineralocorticoid activity is not wanted when treating inflammatory diseases as would lead to side effects
  • When affinity for glucocorticoid receptors is increased, you can use lower doses with fewer side effects
39
Q

Why is oral prednisolone better than oral hydrocortisone for acute exacerbations of asthma?

A

Prednisolone is more potent due to a 1,2 alkene
It has fewer side effects compared to oral hydrocortisone.

40
Q

What is the essential structural for anti-inflammatory activity in steroids?

A

oxygen at C-11 in form of ketone or alcohol

41
Q

How are beclometasone diesters hydrolysed?

A

Beclometasone 17,21-dipropionate diester is a pro-drug.
It is highly lipophilic, aiding absorption in the lung.
Esterase enzymes in the lung cleave the diester to beclometasone 17-monopropionate.
Then the second ester is cleaved to give the beclometasone.

42
Q

What is important about modifications at the 6-position?

A

Do not affect activity and are only for patent avoidance

43
Q

Why is hydrocortisone 17-butyrate much more potent than hydrocortisone?

A

Esterification at the 17-position dramatically increases the potency of hydrocortisone when used topically

44
Q

Why is clobetasol more potent than clobetasone?

A

Alcohol at C-11, extended chain on C-17

45
Q

What is the potency of hydrocortisone?

A

mild up to 2.5% w/w

46
Q

What is the potency of hydrocortisone butyrate?

A

potent at 0.1% w/w

47
Q

What is the potency of clobetasone butyrate?

A

moderate at 0.05% w/w

48
Q

What is the potency of clobetasol propionate?

A

very potent at 0.05% w/w

49
Q

How do you decide on the potency of steroid for each condition?

A

Potency should match severity